Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
2176
CALL
DELISTED
Acceleron Pharma
XLRN
| $4.23M | ﹤0.01% |
79,800
+65,200
| +447% | +$2.97M |
|
2177
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $4.23M | ﹤0.01% |
142,700
-220,000
| -61% | -$6.2M |
|
2178
PUT
Hasbro
HAS
$13.2B
| $4.22M | ﹤0.01% |
40,000
| – | – |
|
2179
Ingevity
NGVT
$2.68B
| $4.22M | ﹤0.01% |
48,344
+23,151
| +92% | +$2.02M |
|
2180
PUT
Clorox
CLX
$12.7B
| $4.22M | ﹤0.01% |
27,500
-20,000
| -42% | -$2.99M |
|
|
DTYL
2181
DELISTED
iPath US Treasury 10-year Bull ETN
DTYL
| $4.22M | ﹤0.01% |
50,000
| – | – |
|
2182
Independent Bank
INDB
$3.97B
| $4.22M | ﹤0.01% |
50,659
+17,269
| +52% | +$1.41M |
|
2183
Brady Corp
BRC
$4.57B
| $4.21M | ﹤0.01% |
73,564
+2,296
| +3% | +$129K |
|
2184
CALL
First Solar
FSLR
$26.9B
| $4.21M | ﹤0.01% |
75,200
-15,100
| -17% | -$829K |
|
2185
Installed Building Products
IBP
$6.49B
| $4.21M | ﹤0.01% |
61,082
+508
| +0.8% | +$34.3K |
|
|
PTLA
2186
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.2M | ﹤0.01% |
175,892
+61,692
| +54% | +$1.7M |
|
|
I
2187
DELISTED
INTELSAT S. A.
I
| $4.19M | ﹤0.01% |
596,390
+402,997
| +208% | +$6.34M |
|
2188
Valvoline
VVV
$4.51B
| $4.19M | ﹤0.01% |
195,739
-108,268
| -36% | -$2.39M |
|
2189
CALL
Masco
MAS
$15.3B
| $4.18M | ﹤0.01% |
87,200
+7,100
| +9% | +$323K |
|
2190
Visteon
VC
$2.78B
| $4.18M | ﹤0.01% |
48,336
-54,042
| -53% | -$4.81M |
|
2191
NETSCOUT
NTCT
$2.79B
| $4.18M | ﹤0.01% |
173,739
+64,634
| +59% | +$1.53M |
|
2192
PUT
Cognizant
CTSH
$26B
| $4.18M | ﹤0.01% |
67,400
-53,300
| -44% | -$3.29M |
|
2193
PUT
Helmerich & Payne
HP
$3.71B
| $4.18M | ﹤0.01% |
92,000
+18,400
| +25% | +$738K |
|
|
TWNK
2194
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $4.17M | ﹤0.01% |
286,551
+54,888
| +24% | +$747K |
|
2195
CALL
Zions Bancorporation
ZION
$10.3B
| $4.16M | ﹤0.01% |
80,200
+39,300
| +96% | +$1.91M |
|
|
UFS
2196
DELISTED
DOMTAR CORPORATION (New)
UFS
| $4.16M | ﹤0.01% |
108,863
-89,051
| -45% | -$3.3M |
|
2197
Hexcel
HXL
$7.82B
| $4.16M | ﹤0.01% |
56,741
-12,005
| -17% | -$922K |
|
2198
PUT
S&P Global
SPGI
$120B
| $4.15M | ﹤0.01% |
15,200
+4,700
| +45% | +$1.22M |
|
2199
CALL
Dollar General
DG
$27.9B
| $4.15M | ﹤0.01% |
26,600
+5,600
| +27% | +$888K |
|
2200
CNX Resources
CNX
$5.2B
| $4.14M | ﹤0.01% |
467,298
-41,094
| -8% | -$321K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.